Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials
Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo · 2026
Read Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials by Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13495816.txt.
Description
Zhang and colleagues argue that combining radiotherapy with immune checkpoint drugs keeps disappointing in large trials for a fixable reason. Those drugs release the brakes on anti-cancer T cells. Their 2026 review focuses on the tumour's regional immune surroundings: the lymph nodes draining the tumour and the immune clusters inside it. Those nodes are where fresh tumour-specific T cells are trained, yet standard radiation fields often blast them along with the tumour, destroying the army the drugs need.
The authors gather preclinical evidence that sparing uninvolved draining nodes and intratumoral immune aggregates preserves the partnership between the two treatments. Practical fixes follow: delay node irradiation until after the checkpoint drug has primed immunity, use advanced imaging to steer dose away from nodes, or choose lower doses and tighter fields. They urge trial designers to treat regional immunity as a design variable.
Catalog record
| CREATOR | Xuanwei Zhang, Hui Wang, Weiyan Tang, Kai Kang, Kateryna Onyshchenko, Taotao Huang, Dan Liu, Jianxin Xue, You Lu, Gabriele Niedermann, Ren Luo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |